{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13(22)"],"submitter":["Correa-Leon YP"],"pubmed_abstract":["The classification of carbapenemases can help guide therapy. The present study evaluated the performance of the CPO detection test, included in the BD Phoenix<sup>™</sup> NMIC-501 panel for the detection and classification of carbapenemases on the representative molecularly characterized strains collection from Mexico. Carbapenem non-susceptible isolates collected in Mexico were included. The clinical isolates (<i>n</i> = 484) comprised <i>Klebsiella pneumoniae</i> (<i>n</i> = 154), <i>Escherichia coli</i> (<i>n</i> = 150), and <i>P. aeruginosa</i> (<i>n</i> = 180). BD Phoenix CPO NMIC-504 and NMIC-501 panels were used for the identification of species, antimicrobial susceptibility tests, and detection of CPOs. For the detection of carbapenemase-encoding genes, <i>E. coli</i> and <i>K. pne"],"journal":["Diagnostics (Basel, Switzerland)"],"pagination":["3417"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10670751"],"repository":["biostudies-literature"],"pubmed_title":["Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in <i>Escherichia coli, Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>."],"pmcid":["PMC10670751"],"pubmed_authors":["Monroy-Colin VA","Padilla-Ibarra C","Quevedo-Ramos MA","Rodriguez-Noriega E","Lopez-Jacome LE","Martinez-Guerra BA","Mena-Ramirez JP","Feliciano-Guzman JM","Velazquez-Acosta MDC","Mireles-Davalos CD","Hernandez-Duran M","Lopez-Gutierrez E","Correa-Leon YP","Perez-Hernandez JM","Garza-Gonzalez E","Perez-Vicelis T"],"additional_accession":[]},"is_claimable":false,"name":"Evaluation of the BD Phoenix Carbapenemase-Producing Organism Panels for the Detection of Carbapenemase Producers in <i>Escherichia coli, Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>.","description":"The classification of carbapenemases can help guide therapy. The present study evaluated the performance of the CPO detection test, included in the BD Phoenix<sup>™</sup> NMIC-501 panel for the detection and classification of carbapenemases on the representative molecularly characterized strains collection from Mexico. Carbapenem non-susceptible isolates collected in Mexico were included. The clinical isolates (<i>n</i> = 484) comprised <i>Klebsiella pneumoniae</i> (<i>n</i> = 154), <i>Escherichia coli</i> (<i>n</i> = 150), and <i>P. aeruginosa</i> (<i>n</i> = 180). BD Phoenix CPO NMIC-504 and NMIC-501 panels were used for the identification of species, antimicrobial susceptibility tests, and detection of CPOs. For the detection of carbapenemase-encoding genes, <i>E. coli</i> and <i>K. pne","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Nov","modification":"2025-04-22T08:08:45.727Z","creation":"2025-04-05T22:26:13.771Z"},"accession":"S-EPMC10670751","cross_references":{"pubmed":["37998553"],"doi":["10.3390/diagnostics13223417"]}}